Myocardial protection by nicorandil during open-heart surgery under cardiopulmonary bypass
Authors:
- N. K. ChinnanNCN. K. Chinnan
- G. D. PuriGPG. D. Puri
- S. K. S. ThingnamSTS. K. S. Thingnam
- 24 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 24 (01) , 26-32
Abstract
To evaluate the myocardial protective effect of nicorandil when used as an adjuvant to cold hyperkalaemic cardioplegia in open-heart surgery. Patients who underwent surgery under cardiopulmonary bypass (CPB) for mitral valve replacement (MVR, 23 patients) or coronary artery bypass grafting (CABG, 24 patients) were entered in a double-blind study. The patients were randomized to a nicorandil Group (N) or placebo Group (P). Nicorandil 0.1 mg kg-1 (Group N), or normal saline (Group P), were administered at three time points: (1) after aortic cannulation, but prior to going on CPB, (2) 5 min before aortic cross-clamping and (3) 5 min before reperfusion. The following variables were studied: (a) time until electromechanical arrest after cardioplegia administration (Tarrest), (b) time until return of electromechanical activity after aortic cross-clamp removal (Trecovery), (c) incidence of postoperative myocardial infarction or low output syndromes (d) dysrhythmias requiring intervention after aortic cross-clamp removal and (e) haemodynamic changes after nicorandil administration. The Tarrest after cardioplegia administration was significantly faster in nicorandil group in both MVR and CABG patients (P 75 IU L-1 in MVR patients was significantly lower in the Group N than in placebo patients (P < 0.05). However, in CABG patients there was no such significant difference. The incidence of dysrhythmias requiring intervention after aortic cross-clamp removal was also less in Group N. Administration of 0.1 mg kg-1 boluses of nicorandil did not cause significant haemodynamic changes or precipitate dysrhythmias in any patient. Nicorandil enhances the myocardial protective effect of cold hyperkalaemic cardioplegia in cardiac surgery patients.Keywords
This publication has 30 references indexed in Scilit:
- Effect of ischaemic preconditioning on regional release of inflammatory markersClinical Science, 2005
- Replacing potassium with nicorandil in cold St. Thomas' Hospital cardioplegia improves preservation of energetics and function in pig heartsThe Annals of Thoracic Surgery, 2004
- Reply to Sidhu and MacGowanEuropean Journal of Cardio-Thoracic Surgery, 2003
- Failure to precondition pathological human myocardiumJACC, 2001
- NicorandilDrugs, 2000
- Developments in cardioprotection: “polarized” arrest as an alternative to “depolarized” arrestThe Annals of Thoracic Surgery, 1999
- Activation of Adenosine Triphosphate-regulated Potassium ChannelsAnesthesiology, 1998
- Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: Possible implications in cardioplegiaThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Effects of intravenous administration of nicorandil on cardiovascular hemodynamics and left ventricular functionThe American Journal of Cardiology, 1989
- Ventricular FibrillationThe Annals of Thoracic Surgery, 1975